A drug designed to combat Tuberous Sclerosis is being trialled at Cardiff University and could also be used to treat autism. Everolimus has already proven effective when used to treat kidney growths and grain tumours - reducing their size in many cases.
Tuberous Sclerosis is a genetic disorder characterised by the development of tumours in many organs, including the skin and kidneys. It can also affect the brain, leading to epilepsy and often ADHD and autism.
For more health stories click here.
More top news
The RSPCA is urging cat owners to be vigilant after two separate cat poisonings. They occurred in Deeside.
Surf Snowdonia has now closed for the winter - eight weeks earlier than planned. It follows a 'serious failure' in the wave machine.
A hearing was held today on whether to hold a second inquest into the death of a five year-old boy who was killed by E. coli poisoning.